OSLO /LONDON ,JANUARY 29th 2021 :EXACT THERAPEUTICS AS ("EXACT-Tx" or the "Company"), a clinical stage precision medicine company today announced that the company's CFOStig Jarle Pettersen , engaged as a part time consultant via his company CFO For Hire AS, will leave the company onJanuary 31st 2021 at the end of his contracted period. EXACT Tx thanks Stig for his valuable contribution since joining the company inJanuary 2019 and in particular for his support during the successful financing and listing on the Merkur Market (Euronext growth) inJuly 2020 . The process of hiring a full time CFO is ongoing and Ole Fegth of Abaci AS will assume CFO responsibilities for the company until ad interim. About EXACT EXACT-Tx is a clinical stage Norwegian biotech company developing a technology platform for targeted therapeutic enhancement - Acoustic Cluster Therapy (ACT®). ACT® sonoporation is a unique approach to ultrasound-mediated, targeted drug enhancement - with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. www.exact-tx.com For more information contact: DrRafiq Hasan CEO EXACT Therapeutics Rafiq@exact-tx.comRichard Hayhurst /Janet Joy Tel +44 7711 821527 richard@rhapr.eu
Click here for more information
© Oslo Bors ASA, source